Related Experiment Videos
Suppression by cyclosporin A of anti-GBM nephritis in rats
T Nagamatsu1, N Kojima, N Kondo
1Department of Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Abstract:
The suppressive effect of cyclosporin A (CyA) on the development of glomerulonephritis was evaluated in rats with either original- or crescentic-type anti-glomerular basement membrane (GBM) nephritis. CyA (2.5, 10 or 20 mg/kg) was given p.o. daily to original-type anti-GBM nephritic rats for 10 days from the day after the injection of anti-GBM serum. The development of the nephritis was dose-dependently suppressed by CyA before the production of specific antibody against rabbit gamma-globulin (the heterologous phase). In addition, CyA suppressed glomerular infiltration of leukocyte subsets (leukocyte with common antigen, T cell, helper T cell, suppressor/cytotoxic T cell, macrophage/monocyte). CyA was given p.o. daily to crescentic-type anti-GBM nephritic rats for 10 days from the 10th day after the injection of anti-GBM serum. CyA-administration caused a distinct suppression of the deterioration of nephritis during the autologous phase. In addition, CyA markedly suppressed the antibody production. The above data indicate that CyA has a beneficial effect on anti-GBM nephritis, and the antinephritic action of this agent may be due to the inhibition of glomerular infiltration of leukocyte subsets as well as the suppression of the antibody production.
Insights
Cyclosporin A (CyA) effectively suppresses anti-glomerular basement membrane (GBM) nephritis in rats. This immunosuppressant reduces inflammation and antibody production, offering a potential therapeutic benefit for this kidney disease.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Anti-glomerular basement membrane (GBM) nephritis is a severe autoimmune kidney disease.
- Understanding the therapeutic potential of immunosuppressants like Cyclosporin A (CyA) is crucial for managing nephritis.
Purpose of the Study:
- To evaluate the suppressive effect of Cyclosporin A (CyA) on the development and progression of anti-GBM nephritis in a rat model.
- To investigate the mechanisms underlying CyA's therapeutic action in different phases of nephritis.
Main Methods:
- Rats with original-type or crescentic-type anti-GBM nephritis were treated with varying doses of CyA.
- Immunohistochemical analysis was used to assess glomerular infiltration of leukocyte subsets.
- Antibody production against rabbit gamma-globulin was measured.
Main Results:
- CyA demonstrated a dose-dependent suppression of nephritis development in the heterologous phase.
- The drug inhibited the infiltration of various leukocyte subsets, including T cells and macrophages, into glomeruli.
- In the autologous phase, CyA suppressed nephritis deterioration and significantly reduced antibody production.
Conclusions:
- Cyclosporin A exhibits a beneficial effect on anti-GBM nephritis in rats.
- CyA's therapeutic action is attributed to the inhibition of leukocyte infiltration and suppression of antibody production.